Risk of Early Adverse Events After Clopidogrel Discontinuation in Patients Undergoing Short-Term Dual Antiplatelet Therapy-Reference-Cited by-同舟云学术

Risk of Early Adverse Events After Clopidogrel Discontinuation in Patients Undergoing Short-Term Dual Antiplatelet Therapy

Published:2017-08 Issue:16 Volume:10 Page:1621-1630
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Piccolo Raffaele,Feres Fausto,Abizaid Alexandre,Gilard Martine,Morice Marie-Claude,Hong Myeong-Ki,Kim Hyo-Soo,Colombo Antonio,Bhatt Deepak L.,Palmerini Tullio,Stone Gregg W.,Windecker Stephan,Valgimigli Marco

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. 2014 ESC/EACTS Guidelines on myocardial revascularization

2. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Levine;J Am Coll Cardiol,2016

3. Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials;Navarese;BMJ,2015

4. Stable coronary artery disease: revascularisation and invasive strategies;Piccolo;Lancet,2015

5. Dual antiplatelet therapy in percutaneous coronary intervention: a tale of 2 decades with new perspectives in the era of new-generation drug-eluting stents;Piccolo;Circ Cardiovasc Interv,2016

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of thrombogenicity in different types of drug‐eluting stents during transition from DAPT to SAPT;Catheterization and Cardiovascular Interventions;2024-05-20

2. Identifying the Incidence, Predictors, Outcomes, and Prevention of Stent Thrombosis (ST) in Post-percutaneous Coronary Revascularization Patients With Drug-Eluting Stents (DES): A Systematic Review;Cureus;2023-09-13

3. Management of patients on antithrombotic therapy with severe infections: a joint clinical consensus statement of the ESC Working Group on Thrombosis, the ESC Working Group on Atherosclerosis and Vascular Biology, and the International Society on Thrombosis and Haemostasis;European Heart Journal;2023-07-13

4. Abbreviated or Standard Antiplatelet Therapy in HBR Patients;JACC: Cardiovascular Interventions;2023-04

5. P2Y12 Inhibitors Monotherapy in Patients Undergoing Complex vs Non-Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials;American Heart Journal;2023-01